Tom and I talk about the Pfizer DPA, and what lessons we can learn from a company that’s been doing it right for more time than most companies have even heard of the FCPA.
Archive for the ‘Pfizer’ Category
01:21: Howard won’t tempt fate again. Believe it.
02:03: Pfizer & Wyeth settle enforcement actions. Tom and I will be doing an entire episode just about that.
04:42: Standard Chartered
21:32: Did Standard Chartered have a “Deceptive Business Plan?” Or did they just follow the law as OFAC has laid it out?
29:44: What happened to the Attorney-Client Privilege?!
32:46: We have to bring Deloitte into it too
37:40: Evasion versus doing what’s legal in a different way (or, is it illegal if you jump through the hoops they set up?)
39:26: Is there such a thing as “reputation risk?”
46:34: SFO is investigating an EADS subsidiary
49:38: News Corp. arrests, Church of England divests
52:43: JP Morgan Chase is my new best friend
Well, I thought I had figured out why the titles were coming on at the wrong time, but I was mistaken. Hmmm…maybe this show will get dismissed.
Tom and I are back from vacation and raring to go. The first section—about half the show—we spend on the Lindsey case. I end up on a bit of a rant.
We have a breakout session on the Compliance Defense with none other than the esteemed FCPA Professor, Mike Koehler. Agree with him or no, there’s no one more knowledgeable anywhere in the world about the history of the FCPA.
- Lindsey, starting at 1:45, takes up a significant amount of time (about 28 minutes)
- Olympus starts at 29:47 (almost 3 minutes)
- Alstom starts at 32:38 (4 1/2 minutes)
- SFO Red Flags starts at 37:06 (1 1/2 minutes)
- Pfizer starts at 38:45 (6 1/2 minutes)
- Finmeccanica starts at 45:33 (about 2 minutes)
Full episode (despite the bars, go ahead and hit play. I’ll work):
————————Breakout Session Below——————————–
Breakout/Conversation/Debate on a Compliance Defense to the FCPA